Musical Group helps ODM, OEM clients tune in to market demands

Aug 16, 2023

Country Business Reports interviews and articles by Discovery Reports

Musical Group is giving its original design and equipment manufacturing (ODM/OEM) clients a distinct advantage in toys, consumer electronics and medical/healthcare devices. With its exceptional research and development (R&D) expertise, market knowledge and vertically integrated production facilities, the company is propelling clients to lead markets with innovative, top-quality and cost-efficient products.

“We combine continuous R&D and market awareness with efficient production capabilities to develop among the most reliable, innovative and competitive items today,” said Christopher Tse, CEO of Musical Group. “We always deliver the best services and products while protecting our clients’ intellectual property rights to help them dominate their respective markets.”

Starting nearly half a century ago in Hong Kong, manufacturing portable audio and video devices and other consumer electronic items, Musical later on diversified into electronic toys and medical/healthcare devices such as electrocardiogram monitors and hygiene products. Its successful ODM/OEM business model is driven by nearly 100 seasoned electronic, mechanical and software engineers based in R&D centres in Hong Kong and mainland China. These are complemented by its vertically integrated production facility in Qingyuan, China, which covers the whole production process from moulding, SMT (surface-mount technology) and die bonding, to assembly and packaging.

Meanwhile, its 1.1 million-square-foot factories in China and northern Vietnam can produce about 15 million toys and consumer electronic products plus hundreds of thousands of medical/healthcare products annually. The factories comply with the international standards on quality management and quality assurance such as ISO9000 and ISO13485, and those of UL Standards, the Federal Communications Commission and Codes of Conduct for the respective products produced.

“We realise the importance of R&D for our clients’ future growth, and as such, actively explore new devices related to nanotechnology, new sensor applications and ageing populations,” Tse said. “We will consistently develop value-added items that have mass-market appeal through continuous innovation. We are also helping our US customers market and launch their medical products in China and other Asian countries.”